Form 4 Doximity, Inc. For: Feb 03 Filed by: Cabral Timothy S

Go back to Form 4 Doximity, Inc. For: Feb 03 Filed by: Cabral Timothy S

Piper Sandler Upgrades Doximity Inc (DOCS) to Overweight

February 7, 2025 8:29 AM EST

Piper Sandler analyst Sean Wieland upgraded Doximity Inc (NYSE: DOCS) from Neutral to Overweight with a price target of $78.00 (from $31.00).

The analyst comments "We did not know when to walk away from our Neutral rating, but we know when to... More